Medico Remedies

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE630Y01024
NSEID: MEDICO
BSEID: 540937

INR

57.78

-0.05 (-0.09%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 94.29 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2024 is 32.65% vs -23.37% in Dec 2023

Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 80.69% vs -35.56% in Dec 2023

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is 13.92% vs -19.71% in Dec 2023

Interest

YoY Growth in quarter ended Dec 2024 is 27.27% vs 10.00% in Dec 2023

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023

Compare Quarterly Results Of Medico Remedies With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

39.49

2,396.57

-2,357.08

-98.35%

Other Operating Income

0.00

Total Operating income

39.49

2,396.57

-2,357.08

-98.35%

Raw Material Cost

30.93

179.72

-148.79

-82.79%

Purchase of Finished goods

0.33

445.60

-445.27

-99.93%

(Increase) / Decrease In Stocks

-2.60

34.08

-36.68

-107.63%

Employee Cost

1.88

521.79

-519.91

-99.64%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

5.84

474.45

-468.61

-98.77%

Total Expenditure (Excl Depreciation)

36.38

1,655.64

-1,619.26

-97.80%

Operating Profit (PBDIT) excl Other Income

3.11

740.93

-737.82

-99.58%

Other Income

1.43

69.82

-68.39

-97.95%

Operating Profit (PBDIT)

4.54

810.75

-806.21

-99.44%

Interest

0.28

199.47

-199.19

-99.86%

Exceptional Items

0.00

Gross Profit (PBDT)

4.26

611.28

-607.02

-99.30%

Depreciation

0.76

87.03

-86.27

-99.13%

Profit Before Tax

3.50

524.25

-520.75

-99.33%

Tax

0.88

107.87

-106.99

-99.18%

Provisions and contingencies

0.00

Profit After Tax

2.62

416.38

-413.76

-99.37%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

2.62

416.38

-413.76

-99.37%

Equity Capital

16.60

40.06

-23.46

-58.56%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

0.32

10.39

-10.07

-96.92%

Diluted Earnings per share

0.32

10.33

-10.01

-96.90%

Operating Profit Margin (Excl OI)

7.88%

30.92%

0.00

-23.04%

Gross Profit Margin

10.79%

25.51%

0.00

-14.72%

PAT Margin

6.63%

17.37%

0.00

-10.74%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 39.49 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 0.36% vs 27.76% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 32.65% vs -23.37% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 2.62 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 69.03% vs -1.90% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 80.69% vs -35.56% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 3.11 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 28.51% vs -13.88% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 13.92% vs -19.71% in Dec 2023

Quarterly - Interest

Interest 0.28 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 33.33% vs 16.67% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 27.27% vs 10.00% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 7.88%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023